Prognose

Analytikernes gennemsnitlige kursmål er 39,06 € (+2,47 %). Medianen er 41,01 € (+7,58 %).

Køb
  8
Behold
  0
Sælg
  0

Diskussioner i communityet

Der er endnu ingen diskussion om dette aktiv.

Start diskussion

  • Concentra Group Holdings Parent Inc reaches all-time high of $35.94

    Shares of Concentra Group Holdings Parent Inc climbed to a record high of $35.94, putting the stock close to its 52-week high; market capitalization is $4.46 billion. Year-to-date the share price is up about 79% and it has risen 67.78% over the past year. For Q2 Concentra reported revenue of $606 million and adjusted earnings per share of $0.52, raised its full-year guidance and cited improved margins and stronger cash flow. S&P Global Ratings upgraded the rating from BB- to BB and also raised certain bond and loan ratings, while adjusted leverage fell to 3.3x with targets of 3x and 2.5x net. » Mere på de.investing.com


  • Concentra announces leadership change and emphasizes strong growth and margin expansion

    Concentra unveils a planned management change effective November 1, with Matthew DiCanio named president and CEO, Tanner Newton as CFO and Keith Newton as executive chairman. The company reports robust operating momentum with above-target patient growth, nine consecutive quarters of meeting or exceeding goals since the IPO, margin expansion and a net leverage ratio of 2.99 at the end of Q2. Growth drivers include onsite services (revenue > $150 million, organic growth > 20%), accelerated new openings and targeted acquisitions; the separation from Select Medical is nearly complete and provides financial flexibility for M&A and share buybacks. » Mere på de.investing.com


  • S&P raises Concentra rating to BB as debt falls

    S&P Global Ratings has raised Concentra’s long-term rating from BB- to BB, and also upgraded the rating on senior secured loans to BB+ and on unsecured bonds to B+. The upgrade was driven by strong operating results, adjusted leverage below 3.5x in the second quarter, and expected improvements to about 3.3x in 2026 and 3.0x in 2027; management’s net-leverage target is 2.5x. S&P praises higher adjusted EBITDA, strong operating cash flows and Concentra’s market-leading position in occupational health, but assigns a stable outlook and warns that persistently high leverage from aggressive M&A or distributions would pose a downgrade risk. » Mere på de.investing.com


  • Concentra opens first medical center in Boise and plans second location in Idaho

    Concentra has opened its first medical center in Boise, offering work-injury treatment, physical therapy, drug testing, DOT exams, pre-employment screenings and occupational health services. The facility complements telemedicine services via Concentra Telemed; a second location in Meridian is expected later this year. As of March 31, 2026, Concentra operated 632 occupational health centers and 411 onsite clinics, reported revenue growth of 15.46%, revenue of $2.23 billion and a market capitalization of $4 billion. » Mere på de.investing.com


  • Concentra exceeds revenue and earnings expectations in Q1 2026

    Concentra reported revenue of $569.6 million for the first quarter of 2026 (up 13.7% year‑over‑year) and earnings per share of $0.40 (up 21%). The On‑Site Health Clinics segment grew 125%, adjusted EBITDA was $120.7 million, and free cash flow jumped to $9.9 million. The stock rose 4.53% in after‑hours trading; the company reaffirmed an optimistic outlook with projected EPS of $1.44 for 2026 and plans to expand with new de novo centers. » Mere på de.investing.com

I 2026 har Concentra Group allerede udloddet 0,16 € i udbytte. Den seneste udlodning fandt sted i august.

Virksomhedstal

I det seneste kvartal havde Concentra Group en omsætning på 549,24 mio. € og et nettoresultat på 58,17 mio. €

(EUR) september 2026
YoY
Omsætning 549,24 mio. 12,53 %
Bruttofortjeneste 172,57 mio. 21,08 %
Nettoresultat 58,17 mio. 41,45 %
EBITDA 119,49 mio. 20,28 %

Fundamentale data

Nøgletal Værdi
Markedsværdi
4,82 mia. €
Antal aktier
126,52 mio.
Højeste/laveste i 52 uger
40,30 € - 17,36 €
Udbytteafkast
0,56 %
Udbytte TTM
0,22 €
Næste udbytte
0,057 €
Beta
0,63
P/E (PE Ratio)
24,76
PEG (PEG Ratio)
0,62
K/I (PB Ratio)
10,49
P/S (PS Ratio)
2,27

Virksomhedsprofil

Concentra Group Holdings Parent, Inc. leverer arbejdsmedicinske ydelser i USA. Virksomheden tilbyder arbejdsmedicinske og forbrugerrettede sundhedsydelser, herunder behandling af arbejdsskader under arbejdsskadeforsikringen, akutklinikker, klinisk testning, forebyggende behandling og ydelser til arbejdsgivere, samt wellnessprogrammer via arbejdsmedicinske centre og klinikker på virksomhedernes egne lokationer. Virksomheden leverer også Concentra Telemed, en telemedicinsk løsning til behandling af arbejdsrelaterede skader og sygdomme, og ydelser til arbejdsgivere; en farmaceutisk løsning under navnet Concentra Pharmacy; samt Concentra Medical Compliance Administration, en tredjepartsadministrator, der hjælper med at administrere testprogrammer for misbrug for arbejdsgivere med reguleret eller ikke-reguleret arbejdsstyrke. Virksomheden blev grundlagt i 1979 og har hjemsted i Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. fungerer som datterselskab af Select Medical Corporation.

Navn
Concentra Group
CEO
Matthew T. DiCanio
Hjemsted Addison, tx
USA
Websted
Branche
Sundhedsudbydere og -tjenester
Børsnotering
25.05.2010
Medarbejdere 9.983

Tickersymboler

Børs Symbol
NYSE
CON
🍪

Parqet  bruger cookies. Læs mere